676502 InhibitorSelect™ VEGF Signaling Pathway Inhibitor Panel

676502
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      676502-1EA
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          1 ea
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA panel containing 15 potent, selective, reversible, and cell-permeable inhibitors useful for the study of multiple signaling pathways activated by VEGF: 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No. 124018); 1 mg of Calcineurin Autoinhibitory Peptide, Cell-permeable (Cat. No. 207001); 5 mg of ET-18-OCH3 (Cat. No. 341207); 500 µg of Go 6983 (Cat. No. 365251); 100 mg of NG-Nitro-L-arginine Methyl Ester, Hydrochloride (Cat. No. 483125); 5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106); 500 µg of cPLA2α Inhibitor (Cat. No. 525143); 1 mg of PI-103 (Cat. No. 528100); 1 mg of PP2 (Cat. No. 529573); 1 mg of SB 203580 (Cat. No. 559389); 1 mg of U0126 (Cat. No. 662005); 5 mg of VEGFR Tyrosine Kinase Inhibitor V (Cat. No. 676501), 5 mg of VEGFR2 Kinase Inhibitor VI, Ki8751 (Cat. No. 676484); 1 mg of VEGFR2 Kinase Inhibitor III, SU5416 (Cat. No. 676487); 1 mg of ZM 336372 (Cat. No. 692000). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.
          Catalogue Number676502
          Brand Family Calbiochem®
          Application Data
          References
          Product Information
          FormSolid
          Hygroscopic Hygroscopic
          Applications
          Biological Information
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Protect from Light Protect from light
          Hygroscopic Hygroscopic
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C, except 662005, which is unstable in solution, and should be reconstituted just prior to use.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          InhibitorSelect™ VEGF Signaling Pathway Inhibitor Panel SDS

          Title

          Safety Data Sheet (SDS) 

          InhibitorSelect™ VEGF Signaling Pathway Inhibitor Panel Certificates of Analysis

          TitleLot Number
          676502
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision29-November-2010 RFH
          Application Data
          DescriptionA panel containing 15 potent and selective inhibitors useful for the study of VEGF signaling pathways. This panel contains the following inhibitors and 15 ml anhydrous DMSO for reconstitution:
          FormSolid
          Intert gas (Yes/No) Packaged under inert gas
          SolubilityDMSO (supplied). Please refer to information provided on the CD for reconstitution information of individual inhibitors.
          Storage -20°C
          Hygroscopic
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C, except 662005, which is unstable in solution, and should be reconstituted just prior to use.
          Toxicity Standard Handling